The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

  
       
         
    STUDIA CHEMIA - Issue no. 2, Tom I / 2019  
         
  Article:   CLOSANTEL AS A POTENTIAL LIPOPOLYSACCHARIDE BIOSYNTHESIS INHIBITOR IN SHIGELLA SONNEI 4303.

Authors:  LAURA DEUTSCH-NAGY, PÉTER URBÁN, HUNOR SZEBENI, BEÁTA ALBERT, BÉLA KOCSIS, FERENC KILÁR. 		 
       
         
  Abstract:  Shigella spp. are Gram-negative intracellular pathogenic bacteria belonging to the family Enterobacteriaceae. The pathophysiological impact of the bacteria is highly related to the composition and structural variability of lipopolysaccharides. Serum sensitivity and biofilm forming ability are correlated with the length of these molecules, while bacteria with truncated lipopolysaccharides are more sensitive to hydrophobic antibiotics. Inhibitors of lipopolysaccharide biosynthesis have the potential to develop new antimicrobial agents or antibiotic adjuvants. Bacterial two-component systems enable bacteria to sense and to respond to the changes in different environmental conditions. This study focuses on the inhibition of the rfaD gene encoding the ADP-L-glycero-D-mannoheptose-6-epimerase, which is involved in the lipopolysaccharide biosynthesis. Although, there are some inhibitors presumed for bacterial two-component systems like Closantel, their impact on lipopolysaccharide biosynthesis has not been examined previously. The Shigella sonnei 4303 strain was involved in the experiments with known lipopolysaccharide structure. The effect of Closantel on lipopolysaccharide biosynthesis and the limitations of its use are presented.

Keywords: lipopolysaccharide, lipooligosaccharide, lipopolysaccharide biosynthesis, Closantel, Shigella sonnei 		 
         
     
         
         
      Back to previous page